News • Pathology solutions provider
Jaap Stuut appointed as Sakura Finetek President
Sakura Finetek Europe has appointed Jaap Stuut as the President and General Manager. He will lead the company's EMEAI division in this role, shaping the its mission, vision, and long-term strategy.
Image source: Sakura Finetek
According to the company, he brings a wealth of experience to Sakura Finetek Europe, having served as CEO of Immunodiagnostics Systems (IDS) since 2017. With over a decade of executive experience, Jaap Struut is highly skilled in market strategy, organisational development, and regulatory compliance, particularly in IVDR.
Before his leadership at IDS, he held vital positions at Novartis and Roche Diagnostics, demonstrating his expertise in strategic management and business development within the healthcare sector.
Jaap Struut studied Medicine at the University of Groningen and holds a Master of Business Administration from the NIMBAS School of Management, University of Bradford. He has refined his skills through executive programs at esteemed institutions such as the London Business School and Harvard Business School.
Born and raised in the Netherlands, Jaap is a native Dutch speaker with professional fluency in English and German. He will be based at Sakura Finetek Europe's Central Office in Alphen aan den Rijn.
"We are thrilled to welcome Jaap Stuut to Sakura Finetek Europe as our new President and General Manager," said Andries Dragt, Vice President of Strategy & Innovation at Sakura Finetek Europe. "Jaap's extensive experience and strategic vision make him an ideal leader to guide our company. We are confident that Sakura Finetek Europe will achieve even greater success under his leadership in the future."
Source: Sakura Finetek
19.04.2024
